ISRCTN65752530已完成未知
Renin Angiotensin SyStem blockade: diabetes nephropathy
Canadian Institutes of Health Research (CIHR) (Canada)0 个研究点目标入组 223 人开始时间: 2004年7月22日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 223
研究概览
简要总结
2011 Results article in https://doi.org/10.2337/dc11-0476 (added 27/10/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with type one diabetes
- •2. Normal Glomerular Filtration Rate (GFR) and Blood Pressure (BP)
- •3. Normoalbuminuria
- •4. Either sex, 18 to 64 years of age
排除标准
- •1. Type one Diabetes Mellitus longer then 20 years
- •2. BP more than 135/85 mmHg
- •3. GFR less than 90 ml/min
- •4. Microalbuminuria
- •5. Soiltary kidney
- •6. Other chronic disease
- •7. Pregnancy or planning pregnancy within two years of randomisation
研究者
相似试验
已完成
2 期
Renin Angiotensin System Study (RASS/B-RASS)Type 1 DiabetesNCT00143949Michael Mauer, MD285
已完成
4 期
The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With HypertensionProteinuriaDiabetesHypertensionNCT00921570Gulhane School of Medicine105
终止
4 期
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric PatientsMicroalbuminuriaMacroalbuminuric Diabetic NephropathyProteinuriaAlbuminuriaDiabetesNCT00961207Cook County Health2
已完成
不适用
Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin SystemType 1 DiabetesHypoglycemiaNCT01116180Louise Faerch9
Unknown
4 期
Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With NephropathyType 2 Diabetes With NephropathyNCT00949351Lerdsin General Hospital80